| |
| |
|
| Insider
Information: |
Cox Carrie Smith |
| Relationship: |
Director |
| City: |
Dallas |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
489,999 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$11,435,465 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
489,999 |
|
|
| Total
Value |
$11,435,465 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
3
|
|
Stock
price went up :
|
2
|
2
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
2.0
|
| Percentage
Gain/Loss : |
 38.3%
|
64.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Texas Instruments Inc |
TXN |
Director |
2024-01-25 |
36,487 |
2004-09-16 |
0 |
Premium* |
|
|
Merck & Co Inc |
MRK |
Executive Vice President |
2009-11-03 |
0 |
2006-05-15 |
0 |
Premium* |
|
|
Cardinal Health Inc |
CAH |
Director |
2022-11-09 |
41,631 |
2009-12-01 |
0 |
Premium* |
|
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2010-06-10 |
0 |
Premium* |
|
|
Electrocore, Inc. |
ECOR |
Director |
2019-06-06 |
21,000 |
2018-08-17 |
0 |
Premium* |
|
|
Selecta Biosciences Inc |
SELB |
Director |
2024-01-02 |
390,881 |
2019-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TXN |
Texas Instruments Inc |
Director |
• • – |
2023-07-31 |
4 |
S |
$180.04 |
$2,890,542 |
D/D |
(16,055) |
35,801 |
0 |
% |
|
| CELG |
Celgene Corp |
Director |
– • – |
2013-10-25 |
4 |
S |
$157.67 |
$2,956,312 |
D/D |
(18,750) |
565 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2020-10-23 |
4 |
S |
$149.31 |
$3,409,978 |
D/D |
(22,838) |
34,065 |
0 |
% |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2020-07-24 |
4 |
S |
$130.00 |
$3,497,650 |
D/D |
(26,905) |
34,065 |
0 |
% |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2019-04-29 |
4 |
S |
$116.08 |
$1,973,572 |
D/D |
(17,002) |
33,299 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-10-29 |
4 |
D |
$106.30 |
$323,684 |
D/D |
(3,045) |
39,535 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2017-07-27 |
4 |
S |
$82.25 |
$1,151,500 |
D/D |
(14,000) |
31,435 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2023-07-31 |
4 |
OE |
$52.93 |
$1,009,483 |
D/D |
16,055 |
51,856 |
0 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2010-06-10 |
4 |
B |
$52.29 |
$29,543 |
D/D |
565 |
565 |
2.39 |
- |
|
| CELG |
Celgene Corp |
Director |
– • – |
2013-10-25 |
4 |
OE |
$51.78 |
$1,311,462 |
D/D |
24,900 |
6,715 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2015-07-28 |
4 |
S |
$50.00 |
$1,100,000 |
D/D |
(22,000) |
28,285 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
Director |
– • – |
2013-05-14 |
4 |
B |
$46.25 |
$20,119 |
D/D |
435 |
14,129 |
2.39 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2020-10-23 |
4 |
OE |
$44.09 |
$1,110,737 |
D/D |
22,838 |
56,903 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2013-07-25 |
4 |
S |
$39.00 |
$585,000 |
D/D |
(15,000) |
24,164 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
– • – |
2007-08-10 |
4 |
B |
$32.88 |
$19,728 |
D/D |
600 |
5,965 |
2.39 |
- |
|
| CAH |
Cardinal Health Inc |
Director |
– • – |
2009-12-01 |
4 |
A |
$32.46 |
$120,005 |
D/D |
3,697 |
3,697 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2020-07-24 |
4 |
OE |
$32.36 |
$877,135 |
D/D |
26,905 |
60,970 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Executive Vice President |
• – – |
2007-05-01 |
4 |
S |
$31.50 |
$14,175,063 |
D/D |
(450,000) |
91,205 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Executive Vice President |
• – – |
2007-04-20 |
4 |
S |
$30.59 |
$13,883,487 |
D/D |
(450,000) |
91,205 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
– • – |
2008-04-25 |
4 |
B |
$29.15 |
$48,797 |
D/D |
1,674 |
10,139 |
2.39 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2015-07-28 |
4 |
OE |
$28.32 |
$686,490 |
D/D |
22,000 |
35,285 |
0 |
- |
|
| CELG |
Celgene Corp |
|
– • – |
2019-10-29 |
4 |
OE |
$25.89 |
$323,625 |
D/D |
12,500 |
42,580 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Executive Vice President |
• – – |
2009-04-01 |
4 |
D |
$23.70 |
$768,947 |
D/D |
(32,445) |
169,534 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
• • – |
2019-04-29 |
4 |
OE |
$23.05 |
$507,719 |
D/D |
17,002 |
50,301 |
0 |
- |
|
| TXN |
Texas Instruments Inc |
Director |
– • – |
2005-01-31 |
4 |
B |
$23.01 |
$9,779 |
D/D |
425 |
2,865 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
